FDA Authorizes Another Covid Shot without Any Clinical Data– slaynews.com
Go to Article
Excerpt from slaynews.com
The U.S. Food and Drug Administration (FDA) has authorized yet another COVID-19 “vaccine” for public use.
The FDA approved a new Covid injection from Maryland-based pharmaceutical giant Novavax.
However, the Novavax injection was authorized for public use without any clinical trial data being provided.
Instead, FDA officials insist that animal testing data was enough to support the decision.
Despite COVID-19 not being a threat to public health, the FDA argues that Novavax’s protein-based vaccine must be pushed out quickly to provide the public with an alternative to the nRNA injections from Moderna and Pfizer.
In a statement, Dr. Peter Marks, who directs the FDA’s Center for Biologics Evaluation and Research, said:
“Today’s authorization provides an additional COVID-19 vaccine option that meets the FDA’s standards for safety, effectiveness, and manufacturing quality needed to support emergency use authorization.”
